Octreotide

Common brands: Sandostatin Lar Depot, Sandostatin, Octreotide, Mycapssa, Afinitor Disperz

Top reporter: Novartis Pharmaceuticals Corporation

Somatostatin Analog [EPC]Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
30,228
Total Reports
13,009
Serious Reports
6,077
Death Reports
30
Reported Reactions
Death Report Ratio: High (20.10%)

Patient Demographics

Male
12,075
Female
14,427

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Octreotide.

# Reaction Reports % of Total
1 DIARRHOEA 4,524
6.7%
2 DEATH 4,169
6.2%
3 FATIGUE 3,497
5.2%
4 MALAISE 3,001
4.5%
5 BLOOD PRESSURE INCREASED 2,966
4.4%
6 NAUSEA 2,943
4.4%
7 NEEDLE ISSUE 2,773
4.1%
8 PAIN 2,575
3.8%
9 ABDOMINAL PAIN 2,458
3.7%
10 MALIGNANT NEOPLASM PROGRESSION 2,458
3.7%
11 BLOOD PRESSURE SYSTOLIC INCREASED 2,386
3.6%
12 ASTHENIA 2,267
3.4%
13 WEIGHT DECREASED 2,264
3.4%
14 INJECTION SITE PAIN 2,186
3.3%
15 HEADACHE 2,065
3.1%
16 VOMITING 2,036
3.0%
17 DIZZINESS 2,028
3.0%
18 DRUG INEFFECTIVE 1,978
2.9%
19 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1,940
2.9%
20 FALL 1,796
2.7%
21 DYSPNOEA 1,671
2.5%
22 OFF LABEL USE 1,648
2.5%
23 ARTHRALGIA 1,642
2.4%
24 BACK PAIN 1,495
2.2%
25 PAIN IN EXTREMITY 1,461
2.2%
26 BODY TEMPERATURE DECREASED 1,454
2.2%
27 PYREXIA 1,382
2.1%
28 COUGH 1,380
2.1%
29 DECREASED APPETITE 1,367
2.0%
30 ABDOMINAL PAIN UPPER 1,260
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.